FULVESTRANT

33512 reported adverse events

Drug classes: Estrogen Receptor Antagonist [EPC]

These side effects are most commonly reported by patients taking FULVESTRANT:

# Side effect Count
0 MALIGNANT NEOPLASM PROGRESSION 4341
1 FATIGUE 4249
2 NAUSEA 3085
3 DEATH 2782
4 DIARRHOEA 2684
5 NEUTROPENIA 2542
6 WHITE BLOOD CELL COUNT DECREASED 2247
7 METASTASES TO BONE 2179
8 NEOPLASM PROGRESSION 2130
9 ASTHENIA 1812
See all common reactions for FULVESTRANT

FULVESTRANT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PIK3CA-ACTIVATED MUTATION 166 0.5000
1 HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER 132 0.3976
2 CARBOHYDRATE ANTIGEN 15-3 INCREASED 253 0.3325
3 ELLIPTOCYTOSIS 26 0.2889
4 CARBOHYDRATE ANTIGEN 27.29 INCREASED 38 0.2533
5 INFUSION SITE COLDNESS 24 0.2400
6 PSEUDOCIRRHOSIS 79 0.2380
7 METASTASES TO THORAX 47 0.1858
8 METASTASES TO EYE 39 0.1781
9 PLEURAL NEOPLASM 29 0.1758
See all enriched reactions for FULVESTRANT